⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIIB News
Biogen Inc. Common Stock
GLP-1 Receptor Agonist Market to Hit USD 78.4 Billion by 2032, Growing at a CAGR of 3.66% with Rising Demand for Metabolic Disease Therapies | MarkNtel Advisors
prnewswire.com
LLY
BIIB
Recludix Pharma Promotes Executive Leaders Following Recent Corporate Accomplishments
globenewswire.com
AMGN
BIIB
MRK
Recludix Pharma Promotes Executive Leaders Following Recent Corporate Accomplishments
globenewswire.com
AMGN
BIIB
MRK
SNY
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Avantor, Inc. (AVTR), Baxter International Inc. (BAX), Biogen Inc. (BIIB), and CarMax, Inc. (KMX)
globenewswire.com
AVTR
BAX
BIIB
KMX
Form 8-K
sec.gov
BIIB
Biogen Presents Additional Salanersen Data Showing New Motor Milestones Achieved in Children with SMA Previously Treated with Gene Therapy
globenewswire.com
BIIB
Biogen Presents Additional Salanersen Data Showing New Motor Milestones Achieved in Children with SMA Previously Treated with Gene Therapy
globenewswire.com
BIIB
Latest data on long-term, real-world treatment with lecanemab will be presented at the AD/PD™ 2026 congress USA - English USA - English
prnewswire.com
BIIB
Latest data on long-term, real-world treatment with lecanemab will be presented at the AD/PD™ 2026 congress USA - English USA - English
prnewswire.com
BIIB
Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD™ 2026 Annual Meeting
prnewswire.com
BIIB